TABLE 3

Use of conventional medications in the two study groups

DrugBaseline2 years4 years
Aspirin
 CR-LIPE57 (57)49 (56)43 (59)
 Control59 (54)45 (60)29 (60)
Statins
 CR-LIPE9 (9)8 (9)7 (10)
 Control7 (8)8 (11)6 (12)
ASI
 CR-LIPE78 (78)67 (76)53 (72)
 Control69 (76)56 (75)34 (70)
Ca2+ antagonist
 CR-LIPE26 (26)24 (27)21 (29)
 Control23 (25)19 (25)14 (29)
Central adrenergic blocker
 CR-LIPE13 (13)15 (17)13 (18)
 Control13 (14)12 (16)10 (21)
β-blocker
 CR-LIPE15 (15)17 (19)15 (20)
 Control16 (18)13 (17)9 (19)
α-blocker
 CR-LIPE11 (11)12 (14)11 (15)
 Control12 (13)10 (13)9 (19)
Diuretic
 CR-LIPE62 (62)55 (63)48 (66)
 Control55 (60)48 (64)31 (65)
Insulin
 CR-LIPE49 (49)41 (47)34 (47)
 Control46 (51)38 (51)26 (54)
Metformin
 CR-LIPE6 (6)5 (6)5 (7)
 Control5 (5)5 (7)4 (8)
Sulfonylurea
 CR-LIPE23 (23)18 (20)14 (19)
 Control24 (26)19 (25)10 (21)
  • Data are n (%)